Rationale and design of the randomised controlled trial to assess the impact of liraglutide on cardiac function and structure in young adults with type 2 diabetes (the LYDIA study)
Crossref DOI link: https://doi.org/10.1186/s12933-016-0421-6
Published Online: 2016-07-21
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Htike, Z. Z.
Yates, T.
Brady, E. M.
Webb, D.
Gray, L. J.
Swarbrick, D.
McCann, G. P.
Khunti, K.
Davies, M. J.
Funding for this research was provided by:
Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit
Novo Nordisk